HealthInvest Partners AB Diversified Active

CIK: 0001381843 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 8, 2021

Total Value ($000): $66,763 (100.0% shares, 0.0% debt)

Holdings (17)

IRWD IRONWOOD PHARMACEUTICALS INC 13.4%

Value ($000) $8,946 Shares 685,000 Est. Cost $10.81 Unrealized +19.5%

SUPN SUPERNUS PHARMACEUTICALS INC 13.4%

Value ($000) $8,934 Shares 335,000 Est. Cost $22.36 Unrealized +20.1%

ARAY ACCURAY INC 11.0%

Value ($000) $7,347 Shares 1,860,000 Est. Cost $4.02 Unrealized -1.3%

HRMY HARMONY BIOSCIENCES HLDGS IN 10.6%

Value ($000) $7,091 Shares 185,000 Est. Cost $32.20 Unrealized 0.0%

— RIGEL PHARMACEUTICALS INC 9.6%

Value ($000) $6,407 Shares 1,765,000 Est. Cost $3.63 Unrealized —

— LANNET INC 8.0%

Value ($000) $5,325 Shares 1,775,000 Est. Cost $3.00 Unrealized —

UTMD UTAH MED PRODS INC 5.8%

Value ($000) $3,899 Shares 42,000 Est. Cost $88.34 Unrealized 0.0%

— ZOGENIX INC 5.0%

Value ($000) $3,342 Shares 220,000 Est. Cost $15.19 Unrealized —

ALDX ALDEYRA THERAPEUTICS INC 4.1%

Value ($000) $2,722 Shares 310,000 Est. Cost $9.18 Unrealized 0.0%

EOLS EVOLUS INC 3.4%

Value ($000) $2,286 Shares 300,000 Est. Cost $10.34 Unrealized 0.0%

COR AMERISOURCEBERGEN CORP 2.5%

Value ($000) $1,672 Shares 14,000 Est. Cost $112.38 Unrealized 0.0%

BMY BRISTOL-MYERS SQUIBB CO 2.5%

Value ($000) $1,657 Shares 28,000 Est. Cost $50.54 Unrealized +8.5%

ABBV ABBVIE INC 2.4%

Value ($000) $1,618 Shares 15,000 Est. Cost $81.92 Unrealized +18.7%

MCK MCKESSON CORP 2.4%

Value ($000) $1,595 Shares 8,000 Est. Cost $166.27 Unrealized +17.3%

CAH CARDINAL HEALTH INC 2.4%

Value ($000) $1,583 Shares 32,000 Est. Cost $48.62 Unrealized +0.5%

URGN UROGEN PHARMA LTD 1.9%

Value ($000) $1,262 Shares 75,000 Est. Cost $15.85 Unrealized 0.0%

— LA JOLLA PHARMACEUTICAL CO 1.6%

Value ($000) $1,077 Shares 270,000 Est. Cost $3.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
IRWD	IRONWOOD PHARMACEUTICALS INC	685,000	$8,946	13.4%	$10.81	+19.5%	COM CL A	46333X108
SUPN	SUPERNUS PHARMACEUTICALS INC	335,000	$8,934	13.4%	$22.36	+20.1%	COM	868459108
ARAY	ACCURAY INC	1,860,000	$7,347	11.0%	$4.02	-1.3%	COM	004397105
HRMY	HARMONY BIOSCIENCES HLDGS IN	185,000	$7,091	10.6%	$32.20	0.0%	COM	413197104
—	RIGEL PHARMACEUTICALS INC	1,765,000	$6,407	9.6%	$3.63	—	COM NEW	766559603
—	LANNET INC	1,775,000	$5,325	8.0%	$3.00	—	COM	516012101
UTMD	UTAH MED PRODS INC	42,000	$3,899	5.8%	$88.34	0.0%	COM	917488108
—	ZOGENIX INC	220,000	$3,342	5.0%	$15.19	—	COM NEW	98978L204
ALDX	ALDEYRA THERAPEUTICS INC	310,000	$2,722	4.1%	$9.18	0.0%	COM	01438T106
EOLS	EVOLUS INC	300,000	$2,286	3.4%	$10.34	0.0%	COM	30052C107
COR	AMERISOURCEBERGEN CORP	14,000	$1,672	2.5%	$112.38	0.0%	COM	03073E105
BMY	BRISTOL-MYERS SQUIBB CO	28,000	$1,657	2.5%	$50.54	+8.5%	COM	110122108
ABBV	ABBVIE INC	15,000	$1,618	2.4%	$81.92	+18.7%	COM	00287Y109
MCK	MCKESSON CORP	8,000	$1,595	2.4%	$166.27	+17.3%	COM	58155Q103
CAH	CARDINAL HEALTH INC	32,000	$1,583	2.4%	$48.62	+0.5%	COM	14149Y108
URGN	UROGEN PHARMA LTD	75,000	$1,262	1.9%	$15.85	0.0%	COM	M96088105
—	LA JOLLA PHARMACEUTICAL CO	270,000	$1,077	1.6%	$3.99	—	COM PAR $.0001 2	503459604